Codes / ICD10CM / R87.621

R87.621 Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Atypical squamous cells cannot exclude high grade squamous intraepithelial lesion on cytologic smear of vagina (ASC-H)

Summary

ASC-H is a cytological finding indicating abnormal squamous cells in a vaginal smear, where high-grade squamous intraepithelial lesion (HSIL) cannot be ruled out. This result suggests a higher risk of significant cellular changes compared to lower-grade abnormalities and requires further evaluation to determine the underlying cause.

Causes

The condition may be associated with persistent infection with high-risk human papillomavirus (HPV) strains, which can lead to cellular changes. Other potential causes include inflammation, hormonal fluctuations, or irritation, though the exact etiology often requires additional testing to confirm.

Risk Factors

  • Persistent high-risk HPV infection
  • Immunocompromised state
  • History of abnormal cervical or vaginal cytology
  • Smoking
  • Multiple sexual partners or early sexual activity

Symptoms

ASC-H is typically asymptomatic and detected during routine screening. When symptoms occur, they may include abnormal vaginal bleeding, unusual discharge, or pelvic discomfort, though these are not specific to the cytological changes.

Diagnosis

Diagnosis involves a cytological test (e.g., Pap smear) identifying atypical cells. Further evaluation, such as colposcopy with biopsy, is usually recommended to assess for high-grade lesions or other abnormalities.

Treatment Options

  • Immediate colposcopy and biopsy to rule out HSIL or cancer.
  • If HSIL is confirmed, treatment may include excisional procedures (e.g., loop electrosurgical excision procedure) or ablation.
  • For persistent ASC-H without HSIL, close monitoring with repeat cytology or HPV testing is standard.

Prognosis and Follow-Up

ASC-H carries a higher risk of underlying high-grade disease compared to lower-grade findings. Follow-up is critical, typically involving repeat testing or colposcopy within 6–12 months to ensure no progression to more severe lesions.

Complications

If left unaddressed, ASC-H may progress to high-grade squamous intraepithelial lesions or invasive cancer. Early evaluation reduces this risk.

Lifestyle & Prevention

  • Regular cervical and vaginal screening as recommended by guidelines.
  • HPV vaccination to reduce infection risk.
  • Avoiding smoking and maintaining a healthy immune system.
  • Safe sexual practices to minimize HPV exposure.

When to Seek Professional Help

Seek care if you experience abnormal vaginal bleeding, persistent discharge, or pelvic pain, or if you receive an ASC-H result requiring follow-up.

Tips for Medical Coders

Document the cytological findings clearly, including the reason for concern about high-grade disease. Ensure the report specifies "cannot exclude high grade" to support the ASC-H diagnosis. Include details of any follow-up procedures (e.g., colposcopy) for accurate coding and clinical context.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

R87.621 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.